NRSN
Neurosense Therapeutics Ltd. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website neurosense-tx.com
- Employees(FY) 14
- ISIN IL0011809592
Performance
+3.08%
1W
-26.67%
1M
-11.68%
3M
+135.41%
6M
+54.14%
YTD
-30.46%
1Y
Profile
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Technical Analysis of NRSN 2024-05-10
Overview:
In analyzing the technical indicators for NRSN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2023-09-18 21:00
- 2023-09-13 21:00
- 2023-09-05 20:30
NeuroSense to Host Investor Webinar on September 12, 2023(Yahoo Finance)
- 2023-08-15 21:00
- 2023-07-16 20:30
- 2023-07-10 21:00
- 2023-07-05 20:30
NeuroSense CEO Provides Q2 2023 Update(Yahoo Finance)
- 2023-06-21 20:30
- 2023-05-31 20:45
- 2023-05-14 21:05
- 2023-05-01 20:30
- 2023-04-16 21:05
- 2023-03-26 21:15
- 2023-03-22 21:05
- 2023-03-21 20:45
- 2023-03-15 20:30
NeuroSense Therapeutics to Participate in BIO-Europe Spring(Yahoo Finance)
- 2023-03-13 20:40
- 2023-02-12 19:30
- 2023-02-09 16:45
- 2023-02-08 20:20
- 2023-02-07 20:14
- 2023-02-05 20:12
- 2023-01-18 19:52
- 2022-11-30 20:05
- 2022-11-15 20:34
- 2022-11-14 19:30
- 2022-10-26 20:50
- 2022-10-20 21:25
- 2022-10-17 20:30
- 2022-10-11 20:30